BMI1 and glioblastoma: These findings show that the effect of miR-128 on glioblastoma cells is consistent with the reduction of Bmi-1 expression, including one with a reduction in self-renewal of glioblastoma stem cells, suggesting that miR-128 may have the potential for clinical translation of glioblastoma stem cells.